GENHLT

Wendy’s customers fall ill, CDC probes E.coli outbreak in four states

A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/Register now for FREE unlimited access to Reuters.comRegisterAug 19 (Reuters) – The U.S. Centers for Disease Control and Prevention said it is probing an E.coli bacteria outbreak in four states from an unknown food …

Wendy’s customers fall ill, CDC probes E.coli outbreak in four states Read More »

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File PhotoRegister now for FREE unlimited access to Reuters.comRegisterAug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved bluebird bio’s (BLUE.O) gene therapy for patients with a rare disorder requiring regular …

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval Read More »

Newly-launched U.S. drugs head toward record-high prices in 2022

Median annual price for new U.S. drugs this year is $257,000Eight of 13 drugs launched in 2022 priced over $200,000 per yearSome drugmakers disclose less information on pricingAug 15 (Reuters) – Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to …

Newly-launched U.S. drugs head toward record-high prices in 2022 Read More »

China approves Genuine Biotech’s HIV drug for COVID patients

BEIJING, July 25 (Reuters) – China on Monday gave conditional approval to domestic firm Genuine Biotech’s Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus.The availability of effective COVID vaccines and treatments is crucial in laying the groundwork for China’s potential pivoting from its “dynamic COVID zero” …

China approves Genuine Biotech’s HIV drug for COVID patients Read More »

Large U.S. law firms mostly quiet on abortion ruling, are walking a ‘tightrope’

June 26 (Reuters) – The largest U.S. law firms did not take a public stance following the U.S. Supreme Court’s reversal of Roe v. Wade on Friday, diverging from the approach of some major companies that have made statements on the closely watched abortion case.The high court’s 6-3 Dobbs decision upheld a Republican-backed Mississippi law …

Large U.S. law firms mostly quiet on abortion ruling, are walking a ‘tightrope’ Read More »